Carnac G, Ricaud S, Vernus B, Bonnieu A (iulie 2006). „Myostatin: biology and clinical relevance”. Mini Reviews in Medicinal Chemistry. 6 (7): 765–70. doi:10.2174/138955706777698642. PMID16842126.
Joulia-Ekaza D, Cabello G (iunie 2007). „The myostatin gene: physiology and pharmacological relevance”. Current Opinion in Pharmacology. 7 (3): 310–5. doi:10.1016/j.coph.2006.11.011. PMID17374508.
Kambadur R, Sharma M, Smith TP, Bass JJ (septembrie 1997). „Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle”. Genome Research. 7 (9): 910–16. doi:10.1101/gr.7.9.910. PMID9314496.
Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibé B, Bouix J, Caiment F, Elsen JM, Eychenne F, Larzul C, Laville E, Meish F, Milenkovic D, Tobin J, Charlier C, Georges M (iulie 2006). „A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep”. Nature Genetics. 38 (7): 813–18. doi:10.1038/ng1810. PMID16751773.
Schuelke M, Wagner KR, Stolz LE, Hübner C, Riebel T, Kömen W, Braun T, Tobin JF, Lee SJ (iunie 2004). „Myostatin mutation associated with gross muscle hypertrophy in a child”. The New England Journal of Medicine. 350 (26): 2682–88. doi:10.1056/NEJMoa040933. PMID15215484.Parametru necunoscut |lay-url= ignorat (ajutor)
Whittemore LA, Song K, Li X, Aghajanian J, Davies M, Girgenrath S, Hill JJ, Jalenak M, Kelley P, Knight A, Maylor R, O'Hara D, Pearson A, Quazi A, Ryerson S, Tan XY, Tomkinson KN, Veldman GM, Widom A, Wright JF, Wudyka S, Zhao L, Wolfman NM (ianuarie 2003). „Inhibition of myostatin in adult mice increases skeletal muscle mass and strength”. Biochemical and Biophysical Research Communications. 300 (4): 965–71. doi:10.1016/s0006-291x(02)02953-4. PMID12559968.
Carnac G, Ricaud S, Vernus B, Bonnieu A (iulie 2006). „Myostatin: biology and clinical relevance”. Mini Reviews in Medicinal Chemistry. 6 (7): 765–70. doi:10.2174/138955706777698642. PMID16842126.
Joulia-Ekaza D, Cabello G (iunie 2007). „The myostatin gene: physiology and pharmacological relevance”. Current Opinion in Pharmacology. 7 (3): 310–5. doi:10.1016/j.coph.2006.11.011. PMID17374508.
Kambadur R, Sharma M, Smith TP, Bass JJ (septembrie 1997). „Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle”. Genome Research. 7 (9): 910–16. doi:10.1101/gr.7.9.910. PMID9314496.
Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibé B, Bouix J, Caiment F, Elsen JM, Eychenne F, Larzul C, Laville E, Meish F, Milenkovic D, Tobin J, Charlier C, Georges M (iulie 2006). „A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep”. Nature Genetics. 38 (7): 813–18. doi:10.1038/ng1810. PMID16751773.
Tsuchida K (iulie 2008). „Targeting myostatin for therapies against muscle-wasting disorders”. Current Opinion in Drug Discovery & Development. 11 (4): 487–94. PMID18600566.
Schuelke M, Wagner KR, Stolz LE, Hübner C, Riebel T, Kömen W, Braun T, Tobin JF, Lee SJ (iunie 2004). „Myostatin mutation associated with gross muscle hypertrophy in a child”. The New England Journal of Medicine. 350 (26): 2682–88. doi:10.1056/NEJMoa040933. PMID15215484.Parametru necunoscut |lay-url= ignorat (ajutor)
Whittemore LA, Song K, Li X, Aghajanian J, Davies M, Girgenrath S, Hill JJ, Jalenak M, Kelley P, Knight A, Maylor R, O'Hara D, Pearson A, Quazi A, Ryerson S, Tan XY, Tomkinson KN, Veldman GM, Widom A, Wright JF, Wudyka S, Zhao L, Wolfman NM (ianuarie 2003). „Inhibition of myostatin in adult mice increases skeletal muscle mass and strength”. Biochemical and Biophysical Research Communications. 300 (4): 965–71. doi:10.1016/s0006-291x(02)02953-4. PMID12559968.